Scoop has an Ethical Paywall
Licence needed for work use Learn More

Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Disparity on price of antihistamines

5 October 2017

Pharmacies charge up to twice the price of others for antihistamines, Consumer NZ finds

Allergy sufferers can slash their antihistamine bill in half by shopping around, a Consumer NZ investigation has found.

While one Christchurch pharmacy sold a 90-pack of Razene (the antihistamine cetirizine) for $66.90, across town another pharmacy charged just $37.99. A Wellington pharmacy charged its customers $30 for Razene 90s.

“We were surprised to see such extreme differences in price for the same product, sometimes at outlets belonging to the same chain. This demonstrates how important it is for consumers buying antihistamines to shop around,” Consumer NZ chief executive Sue Chetwin says.

As allergy season approached, Consumer NZ compared prices at 30 pharmacies in Auckland, Wellington and Christchurch for seven commonly stocked antihistamine products. Of the seven, four were “generics”, with the same active ingredient and effect on the body as big name brands, such as Claratyne (loratadine), Telfast (fexofenadine) and Zyrtec (cetirizine).

Across all 30 pharmacies, the cheapest packet of 30 pills of Telfast 180mg was $44.99. The most expensive was $22 more ($66.99).

There was a similar price variation for Claratyne 30s – the lowest-priced packet in the survey cost $23.50 and the highest-priced $44.90.

“We found the cheapest prices for five of our seven surveyed products were offered by an online-only pharmacy, even after delivery fees were factored in. Buying online is a good way to cut the cost of your antihistamine bill,” Ms Chetwin says.

Full results of the price survey can be found at consumer.org.nz and in the October edition of Consumer magazine.


ends

Advertisement - scroll to continue reading

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Business Headlines | Sci-Tech Headlines

 
 
 
 
 
 
 
 
 
 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.